The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
ampicillin and sulbactam · AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g/1 · Injection, Powder, For Solution · Intravenous · Avenacy, LLC
NDC 83634-0108-99 · 1 BOTTLE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE · ANDA · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Avenacy, LLC | AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, LLC | AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, LLC | AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | AMPICILLIN SODIUM 2 g/3g; SULBACTAM SODIUM 1 g/3g | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | AMPICILLIN SODIUM 1 g/1.5g; SULBACTAM SODIUM .5 g/1.5g | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | SULBACTAM SODIUM 1 g/1; AMPICILLIN SODIUM 2 g/1 | Aug 26, 2026 | Aug 28, 2026 |
| WG Critical Care, LLC | SULBACTAM SODIUM 2 g/1; AMPICILLIN SODIUM 1 g/1 | Jul 22, 2026 | Aug 22, 2026 |
| WG Critical Care, LLC | AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 | Jul 15, 2026 | Jul 19, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Ampicillin and Sulbactam — NDC 83634-0108-99," retrieved September 3, 2026, https://drugdashboards.com/drug/83634010899.
Free to cite with attribution — see how the data is put together.